Guevarra also stressed that transparency on the vaccine’s efficacy and safety should be observed at the earliest opportunity, “even prior to the choice of vaccine and negotiation with the prospective provider.”
Full Post on Source: Guevarra: 'Absolute transparency' on vaccine's efficacy, safety necessary
